| Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer (NCT00004232) | Northwestern University | 1999-10-01 |
| Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma (NCT00004903) | Robert H. Lurie Cancer Center | 1999-10-01 |
| Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leukemia, or Agnogenic Myeloid Metaplasia (NCT00004181) | Northwestern University | 1999-10-01 |
| Stem Cell Transplantation in Treating Patients With Hematologic Cancer (NCT00004904) | Northwestern University | 1999-10-01 |
| Bone Marrow Transplantation in Treating Patients With Hematologic Cancer (NCT00005804) | Fred Hutchinson Cancer Center | 1999-10-01 |
| Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer (NCT00290628) | Masonic Cancer Center, University of Minnesota | 1999-10-01 |
| O6-benzylguanine And Carmustine in Treating Patients With Multiple Myeloma (NCT00004072) | Case Comprehensive Cancer Center | 1999-09-01 |
| Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma (NCT00021359) | Fox Chase Cancer Center | 1999-08-01 |
| Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis (NCT00007995) | Herbert Irving Comprehensive Cancer Center | 1999-07-01 |
| Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy (NCT00006220) | Washington University School of Medicine | 1999-06-01 |
| Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma (NCT00004158) | Fred Hutchinson Cancer Center | 1999-06-01 |
| Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer (NCT00005092) | M.D. Anderson Cancer Center | 1999-05-28 |
| Combination Chemo, Peripheral Stem Cell Transplant, Biological Therapy, Pamidronate and Thalidomide for Multiple Myeloma (NCT00004088) | City of Hope Medical Center | 1999-04-13 |
| 4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis (NCT00003853) | National Cancer Institute (NCI) | 1999-04-01 |
| Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma (NCT00003401) | University of Maryland, Baltimore | 1999-01-01 |
| Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer (NCT00296023) | University of California, San Francisco | 1999-01-01 |
| Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy (NCT00003600) | Alliance for Clinical Trials in Oncology | 1998-12-01 |
| High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis (NCT00003353) | Eastern Cooperative Oncology Group | 1998-11-16 |
| Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer (NCT00004145) | University of Chicago | 1998-11-01 |
| Combination Chemotherapy in Treating Patients With Multiple Myeloma (NCT00003493) | The Cleveland Clinic | 1998-11-01 |
| Rituximab in Treating Patients With Multiple Myeloma (NCT00003554) | The Cleveland Clinic | 1998-11-01 |
| Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma (NCT00003490) | The Cleveland Clinic | 1998-10-01 |
| Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma (NCT00003399) | University of Maryland, Baltimore | 1998-09-01 |
| Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer (NCT00003396) | University of Maryland, Baltimore | 1998-09-01 |
| Bone Marrow Transplantation in Treating Patients With Hematologic Cancer (NCT00003398) | University of Maryland, Baltimore | 1998-09-01 |
| Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers (NCT00003572) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1998-08-01 |
| Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation (NCT00003887) | Fred Hutchinson Cancer Center | 1998-08-01 |
| Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer (NCT00003451) | National Cancer Institute (NCI) | 1998-08-01 |
| Biological Therapy in Treating Patients With Multiple Myeloma That Has Recurred Following Bone Marrow Transplantation (NCT00003153) | Eastern Cooperative Oncology Group | 1998-07-22 |
| Treatment for Chronic Pain in Patients With Advanced Cancer (NCT00003687) | NCIC Clinical Trials Group | 1998-06-11 |
| Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After Chemotherapy (NCT00004040) | Hoag Memorial Hospital Presbyterian | 1998-06-01 |
| Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer (NCT00003408) | Cancer Treatment Centers of America | 1998-04-01 |
| Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer (NCT00003395) | Memorial Sloan Kettering Cancer Center | 1998-04-01 |
| Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer (NCT00003962) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1998-04-01 |
| Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders (NCT00008307) | Herbert Irving Comprehensive Cancer Center | 1998-04-01 |
| Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer (NCT00003960) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1998-04-01 |
| Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma (NCT00003603) | Riverside Haematology Group | 1998-03-01 |
| Combination Chemotherapy in Treating Patients With Advanced Cancer (NCT00003331) | NYU Langone Health | 1998-01-01 |
| Tocladesine in Treating Patients With Recurrent or Refractory Multiple Myeloma (NCT00004902) | Northwestern University | 1998-01-01 |
| Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma (NCT00003195) | Fred Hutchinson Cancer Center | 1997-12-01 |
| Interleukin-12 in Treating Patients With Multiple Myeloma (NCT00003149) | Eastern Cooperative Oncology Group | 1997-12-01 |
| Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer (NCT00003082) | University of Arizona | 1997-12-01 |
| Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or Myeloma (NCT00003885) | Our Lady of Mercy Medical Center | 1997-11-01 |
| Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer (NCT00004036) | The Cleveland Clinic | 1997-11-01 |
| Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma (NCT00003146) | Fred Hutchinson Cancer Center | 1997-11-01 |
| Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors (NCT00003107) | Indiana University | 1997-10-01 |
| Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer (NCT00003270) | Roswell Park Cancer Institute | 1997-09-04 |
| Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers (NCT00003163) | Medical College of Wisconsin | 1997-09-01 |
| Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation (NCT00005641) | H. Lee Moffitt Cancer Center and Research Institute | 1997-09-01 |
| Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT00002878) | Eastern Cooperative Oncology Group | 1997-06-30 |
| Decitabine in Treating Patients With Melanoma or Other Advanced Cancer (NCT00002980) | California Cancer Consortium | 1997-05-01 |
| Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome (NCT00002989) | European Organisation for Research and Treatment of Cancer - EORTC | 1997-03-01 |
| Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma (NCT00002907) | Barbara Ann Karmanos Cancer Institute | 1997-01-01 |
| Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia (NCT00008164) | Herbert Irving Comprehensive Cancer Center | 1997-01-01 |
| Combination Chemotherapy in Treating Patients With Stage II or Stage III Multiple Myeloma (NCT00006232) | West of Scotland Lymphoma Group | 1996-10-01 |
| Interferon Alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple Myeloma (NCT00003007) | University of Tennessee | 1996-07-01 |
| Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer (NCT00008216) | Columbia University | 1996-07-01 |
| Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplant (NCT00005852) | H. Lee Moffitt Cancer Center and Research Institute | 1996-06-01 |
| High-Dose Melphalan Followed by Peripheral Stem Cell Transplant in Treating Patients With Amyloidosis (NCT00002810) | Temple University | 1996-05-01 |
| Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer (NCT00002742) | Aronex Pharmaceuticals | 1996-01-01 |
| Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss (NCT00003077) | Alliance for Clinical Trials in Oncology | 1995-10-01 |
| Combination Chemotherapy in Treating Patients With Multiple Myeloma (NCT00002678) | NCIC Clinical Trials Group | 1995-06-02 |
| SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant (NCT00002657) | SWOG Cancer Research Network | 1995-05-01 |
| Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease (NCT00002652) | University of Arkansas | 1995-05-01 |
| High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies (NCT00002818) | Virginia Commonwealth University | 1995-02-01 |
| Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma (NCT00002599) | Medical Research Council | 1994-09-01 |
| Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma (NCT00002552) | Barbara Ann Karmanos Cancer Institute | 1993-10-01 |
| Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma (NCT00002653) | Medical Research Council | 1993-09-01 |
| High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma in First Relapse (NCT00002630) | Mayo Clinic | 1993-06-01 |
| Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome (NCT00002502) | Memorial Sloan Kettering Cancer Center | 1992-07-01 |
| High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors (NCT00060255) | Roswell Park Cancer Institute | 1991-12-01 |
| Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma (NCT00900055) | OHSU Knight Cancer Institute | 1975-06-01 |
| Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies (NCT01101412) | M.D. Anderson Cancer Center | |
| SU006668 in Treating Patients With Advanced Solid Tumors (NCT00024063) | Jonsson Comprehensive Cancer Center | |